These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
258 related articles for article (PubMed ID: 25491724)
1. GCN2 is required to increase fibroblast growth factor 21 and maintain hepatic triglyceride homeostasis during asparaginase treatment. Wilson GJ; Lennox BA; She P; Mirek ET; Al Baghdadi RJ; Fusakio ME; Dixon JL; Henderson GC; Wek RC; Anthony TG Am J Physiol Endocrinol Metab; 2015 Feb; 308(4):E283-93. PubMed ID: 25491724 [TBL] [Abstract][Full Text] [Related]
2. The eukaryotic initiation factor 2 kinase GCN2 protects against hepatotoxicity during asparaginase treatment. Wilson GJ; Bunpo P; Cundiff JK; Wek RC; Anthony TG Am J Physiol Endocrinol Metab; 2013 Nov; 305(9):E1124-33. PubMed ID: 24002574 [TBL] [Abstract][Full Text] [Related]
3. General control nonderepressible 2 deletion predisposes to asparaginase-associated pancreatitis in mice. Phillipson-Weiner L; Mirek ET; Wang Y; McAuliffe WG; Wek RC; Anthony TG Am J Physiol Gastrointest Liver Physiol; 2016 Jun; 310(11):G1061-70. PubMed ID: 26968207 [TBL] [Abstract][Full Text] [Related]
4. GCN2 protein kinase is required to activate amino acid deprivation responses in mice treated with the anti-cancer agent L-asparaginase. Bunpo P; Dudley A; Cundiff JK; Cavener DR; Wek RC; Anthony TG J Biol Chem; 2009 Nov; 284(47):32742-9. PubMed ID: 19783659 [TBL] [Abstract][Full Text] [Related]
5. Obesity challenges the hepatoprotective function of the integrated stress response to asparaginase exposure in mice. Nikonorova IA; Al-Baghdadi RJT; Mirek ET; Wang Y; Goudie MP; Wetstein BB; Dixon JL; Hine C; Mitchell JR; Adams CM; Wek RC; Anthony TG J Biol Chem; 2017 Apr; 292(16):6786-6798. PubMed ID: 28242759 [TBL] [Abstract][Full Text] [Related]
6. Time-resolved analysis of amino acid stress identifies eIF2 phosphorylation as necessary to inhibit mTORC1 activity in liver. Nikonorova IA; Mirek ET; Signore CC; Goudie MP; Wek RC; Anthony TG J Biol Chem; 2018 Apr; 293(14):5005-5015. PubMed ID: 29449374 [TBL] [Abstract][Full Text] [Related]
7. The eIF2 kinase GCN2 is essential for the murine immune system to adapt to amino acid deprivation by asparaginase. Bunpo P; Cundiff JK; Reinert RB; Wek RC; Aldrich CJ; Anthony TG J Nutr; 2010 Nov; 140(11):2020-7. PubMed ID: 20861212 [TBL] [Abstract][Full Text] [Related]
8. Liver GCN2 controls hepatic FGF21 secretion and modulates whole body postprandial oxidation profile under a low-protein diet. Chalvon-Demersay T; Moro J; Even PC; Chaumontet C; Tomé D; Averous J; Piedcoq J; Gaudichon C; Maurin AC; Fafournoux P; Azzout-Marniche D Am J Physiol Endocrinol Metab; 2019 Dec; 317(6):E1015-E1021. PubMed ID: 31573843 [TBL] [Abstract][Full Text] [Related]
9. Role of activating transcription factor 4 in the hepatic response to amino acid depletion by asparaginase. Al-Baghdadi RJT; Nikonorova IA; Mirek ET; Wang Y; Park J; Belden WJ; Wek RC; Anthony TG Sci Rep; 2017 Apr; 7(1):1272. PubMed ID: 28455513 [TBL] [Abstract][Full Text] [Related]
10. Dietary Methionine Restriction Regulates Liver Protein Synthesis and Gene Expression Independently of Eukaryotic Initiation Factor 2 Phosphorylation in Mice. Pettit AP; Jonsson WO; Bargoud AR; Mirek ET; Peelor FF; Wang Y; Gettys TW; Kimball SR; Miller BF; Hamilton KL; Wek RC; Anthony TG J Nutr; 2017 Jun; 147(6):1031-1040. PubMed ID: 28446632 [No Abstract] [Full Text] [Related]
11. Rapid increase in fibroblast growth factor 21 in protein malnutrition and its impact on growth and lipid metabolism. Ozaki Y; Saito K; Nakazawa K; Konishi M; Itoh N; Hakuno F; Takahashi S; Kato H; Takenaka A Br J Nutr; 2015 Nov; 114(9):1410-8. PubMed ID: 26330054 [TBL] [Abstract][Full Text] [Related]
12. GCN2 Deficiency Enhances Protective Effects of Exercise on Hepatic Steatosis. Luo X; Shi X; Sun Z; Xiao J; Song H; Lu G; Xu X Biomed Res Int; 2020; 2020():1454396. PubMed ID: 33299856 [TBL] [Abstract][Full Text] [Related]
13. GCN2 drives diurnal patterns in the hepatic integrated stress response and maintains circadian rhythms in whole body metabolism during amino acid insufficiency. Levy JL; Mirek ET; Rodriguez EM; Tolentino MJ; Zalma BA; Roepke TA; Wek RC; Cao R; Anthony TG Am J Physiol Endocrinol Metab; 2024 Oct; 327(4):E563-E576. PubMed ID: 39196798 [TBL] [Abstract][Full Text] [Related]
14. Age modulates liver responses to asparaginase-induced amino acid stress in mice. Nikonorova IA; Zhu Q; Signore CC; Mirek ET; Jonsson WO; Kong B; Guo GL; Belden WJ; Anthony TG J Biol Chem; 2019 Sep; 294(38):13864-13875. PubMed ID: 31413113 [TBL] [Abstract][Full Text] [Related]
15. Modulation of GCN2/eIF2α/ATF4 Pathway in the Liver and Induction of FGF21 in Young Goats Fed a Protein- and/or Phosphorus-Reduced Diet. Weber SL; Hustedt K; Schnepel N; Visscher C; Muscher-Banse AS Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108315 [TBL] [Abstract][Full Text] [Related]
16. The GCN2 eIF2alpha kinase regulates fatty-acid homeostasis in the liver during deprivation of an essential amino acid. Guo F; Cavener DR Cell Metab; 2007 Feb; 5(2):103-14. PubMed ID: 17276353 [TBL] [Abstract][Full Text] [Related]
17. GCN2 in the brain programs PPARγ2 and triglyceride storage in the liver during perinatal development in response to maternal dietary fat. Xu X; Hu J; McGrath BC; Cavener DR PLoS One; 2013; 8(10):e75917. PubMed ID: 24130751 [TBL] [Abstract][Full Text] [Related]
18. Lack of overt FGF21 resistance in two mouse models of obesity and insulin resistance. Hale C; Chen MM; Stanislaus S; Chinookoswong N; Hager T; Wang M; Véniant MM; Xu J Endocrinology; 2012 Jan; 153(1):69-80. PubMed ID: 22067317 [TBL] [Abstract][Full Text] [Related]
19. Response to carbohydrate and fat refeeding in the expression of genes involved in nutrient partitioning and metabolism: striking effects on fibroblast growth factor-21 induction. Sánchez J; Palou A; Picó C Endocrinology; 2009 Dec; 150(12):5341-50. PubMed ID: 19837871 [TBL] [Abstract][Full Text] [Related]
20. Fibroblast growth factor 21 regulates lipolysis in white adipose tissue but is not required for ketogenesis and triglyceride clearance in liver. Hotta Y; Nakamura H; Konishi M; Murata Y; Takagi H; Matsumura S; Inoue K; Fushiki T; Itoh N Endocrinology; 2009 Oct; 150(10):4625-33. PubMed ID: 19589869 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]